Literature DB >> 21514569

The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Brion S Maher1, Vladimir I Vladimirov, Shawn J Latendresse, Dawn L Thiselton, Rebecca McNamee, Moonsu Kang, Tim B Bigdeli, Xiangning Chen, Brien P Riley, John M Hettema, Howard Chilcoat, Christian Heidbreder, Pierandrea Muglia, E Lenn Murrelle, Danielle M Dick, Fazil Aliev, Arpana Agrawal, Howard J Edenberg, John Kramer, John Nurnberger, Jay A Tischfield, Bernie Devlin, Robert E Ferrell, Galina P Kirillova, Ralph E Tarter, Kenneth S Kendler, Michael M Vanyukov.   

Abstract

BACKGROUND: The liability to addiction has been shown to be highly genetically correlated across drug classes, suggesting nondrug-specific mechanisms.
METHODS: In 757 subjects, we performed association analysis between 1536 single nucleotide polymorphisms (SNPs) in 106 candidate genes and a drug use disorder diagnosis (DUD).
RESULTS: Associations (p ≤ .0008) were detected with three SNPs in the arginine vasopressin 1A receptor gene, AVPR1A, with a gene-wise p value of 3 × 10(-5). Bioinformatic evidence points to a role for rs11174811 (microRNA binding site disruption) in AVPR1A function. Based on literature implicating AVPR1A in social bonding, we tested spousal satisfaction as a mediator of the association of rs11174811 with the DUD. Spousal satisfaction was significantly associated with DUD in males (p < .0001). The functional AVPR1A SNP, rs11174811, was associated with spousal satisfaction in males (p = .007). Spousal satisfaction was a significant mediator of the relationship between rs11174811 and DUD. We also present replication of the association in males between rs11174811 and substance use in one clinically ascertained (n = 1399) and one epidemiologic sample (n = 2231). The direction of the association is consistent across the clinically-ascertained samples but reversed in the epidemiologic sample. Lastly, we found a significant impact of rs11174811 genotype on AVPR1A expression in a postmortem brain sample.
CONCLUSIONS: The findings of this study call for expansion of research into the role of the arginine vasopressin and other neuropeptide system variation in DUD liability.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514569      PMCID: PMC4083653          DOI: 10.1016/j.biopsych.2011.02.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  53 in total

Review 1.  Liability to substance use disorders: 2. A measurement approach.

Authors:  Michael M Vanyukov; Levent Kirisci; Ralph E Tarter; Howard F Simkevitz; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

Review 2.  Liability to substance use disorders: 1. Common mechanisms and manifestations.

Authors:  Michael M Vanyukov; Ralph E Tarter; Levent Kirisci; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

3.  Identifying shared environmental contributions to early substance use: the respective roles of peers and parents.

Authors:  Brent Walden; Matt McGue; William G Lacono; S Alexandra Burt; Irene Elkins
Journal:  J Abnorm Psychol       Date:  2004-08

4.  The importance of bonding to school for healthy development: findings from the Social Development Research Group.

Authors:  Richard F Catalano; Kevin P Haggerty; Sabrina Oesterle; Charles B Fleming; J David Hawkins
Journal:  J Sch Health       Date:  2004-09       Impact factor: 2.118

5.  Mate selection-a selection for a handicap.

Authors:  A Zahavi
Journal:  J Theor Biol       Date:  1975-09       Impact factor: 2.691

6.  The 5' flanking region of the monogamous prairie vole oxytocin receptor gene directs tissue-specific expression in transgenic mice.

Authors:  L J Young; K G Waymire; R Nilsen; G R Macgregor; Z Wang; T R Insel
Journal:  Ann N Y Acad Sci       Date:  1997-01-15       Impact factor: 5.691

Review 7.  Neural control of maternal behaviour and olfactory recognition of offspring.

Authors:  K M Kendrick; A P Da Costa; K D Broad; S Ohkura; R Guevara; F Lévy; E B Keverne
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

8.  Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters.

Authors:  C F Ferris; R H Melloni; G Koppel; K W Perry; R W Fuller; Y Delville
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

9.  Substance use among high-school students: relationships with temperament, personality traits, and parental care perception.

Authors:  G Gerra; L Angioni; A Zaimovic; G Moi; M Bussandri; S Bertacca; G Santoro; S Gardini; R Caccavari; M A Nicoli
Journal:  Subst Use Misuse       Date:  2004-01       Impact factor: 2.164

10.  Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice.

Authors:  Isadora F Bielsky; Shuang-Bao Hu; Kathleen L Szegda; Heiner Westphal; Larry J Young
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

View more
  23 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  Are genetic variations in OXTR, AVPR1A, and CD38 genes important to social integration? Results from two large U.S. cohorts.

Authors:  Shun-Chiao Chang; M Maria Glymour; Marissa Rewak; Marilyn C Cornelis; Stefan Walter; Karestan C Koenen; Ichiro Kawachi; Liming Liang; Eric J Tchetgen Tchetgen; Laura D Kubzansky
Journal:  Psychoneuroendocrinology       Date:  2013-10-01       Impact factor: 4.905

3.  Drug addiction and stress-response genetic variability: association study in African Americans.

Authors:  Orna Levran; Matthew Randesi; Yi Li; John Rotrosen; Jurg Ott; Miriam Adelson; Mary Jeanne Kreek
Journal:  Ann Hum Genet       Date:  2014-04-26       Impact factor: 1.670

4.  Functions of arginine vasopressin and its receptors: importance of human molecular genetics studies in bidirectional translational research.

Authors:  Mary Jeanne Kreek; Yan Zhou; Orna Levran
Journal:  Biol Psychiatry       Date:  2011-09-15       Impact factor: 13.382

5.  Association of cognitive function and liability to addiction with childhood herpesvirus infections: A prospective cohort study.

Authors:  Michael M Vanyukov; Vishwajit L Nimgaonkar; Levent Kirisci; Galina P Kirillova; Maureen D Reynolds; Konasale Prasad; Ralph E Tarter; Robert H Yolken
Journal:  Dev Psychopathol       Date:  2017-04-19

Review 6.  Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective.

Authors:  Michael M Vanyukov; Ralph E Tarter; Galina P Kirillova; Levent Kirisci; Maureen D Reynolds; Mary Jeanne Kreek; Kevin P Conway; Brion S Maher; William G Iacono; Laura Bierut; Michael C Neale; Duncan B Clark; Ty A Ridenour
Journal:  Drug Alcohol Depend       Date:  2012-01-18       Impact factor: 4.492

7.  Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.

Authors:  O Levran; E Peles; M Randesi; Y Li; J Rotrosen; J Ott; M Adelson; M J Kreek
Journal:  Psychoneuroendocrinology       Date:  2014-04-06       Impact factor: 4.905

Review 8.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

9.  The Role of Emergence in Genetically Informed Relationships Research: A Methodological Analysis.

Authors:  Jessica E Salvatore; Kenneth S Kendler
Journal:  Behav Genet       Date:  2018-10-24       Impact factor: 2.805

10.  Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin.

Authors:  Amy D Marshall
Journal:  Biol Psychol       Date:  2013-03-05       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.